<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05122962</url>
  </required_header>
  <id_info>
    <org_study_id>21-005062</org_study_id>
    <secondary_id>R01HL158517</secondary_id>
    <nct_id>NCT05122962</nct_id>
  </id_info>
  <brief_title>Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot</brief_title>
  <acronym>PACT</acronym>
  <official_title>Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being done to determine the mechanism(s) contributing to the onset of symptoms&#xD;
      (i.e. shortness of breath and/or palpitations) as well as changes in right heart structure in&#xD;
      patients with Tetralogy of Fallot (TOF).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">October 2026</completion_date>
  <primary_completion_date type="Anticipated">October 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Right Heart Remodeling</measure>
    <time_frame>24 Months</time_frame>
    <description>Right Heart Remodeling measured via right atrial reservoir strain (%).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incident arrhythmias</measure>
    <time_frame>24 Months</time_frame>
    <description>Incident of atrial flutter, atrial fibrillation, atrial tachycardia, and/or ventricular tachycardia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aerobic Capacity</measure>
    <time_frame>24 Months</time_frame>
    <description>Aerobic Capacity measured as maximal oxygen consumption (ml/kg/min).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Tetralogy of Fallot</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Remote Heart Rhythm Monitoring</intervention_name>
    <description>We will be looking to see if remote heart rhythm monitoring for 3 months at baseline, 12, and 24 months, helps for early identification of adverse cardiac events.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This will be a prospective study of patients with repaired Tetralogy of Fallot (TOF) and&#xD;
        pulmonary regurgitation (PR) receiving care at Mayo Clinic Rochester, MN.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Moderate (or greater) PR based on quantitative Doppler echocardiography.&#xD;
&#xD;
          -  Repaired TOF&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant Women&#xD;
&#xD;
          -  Unable to undergo CMRI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Egbe, MBBS, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Halley Davison</last_name>
    <phone>507-422-6246</phone>
    <email>RSTACHDRESPRG@mayo.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evie Schuchard</last_name>
      <phone>507-293-2565</phone>
      <email>ACHDRESPRG@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 4, 2021</study_first_submitted>
  <study_first_submitted_qc>November 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2021</study_first_posted>
  <last_update_submitted>November 4, 2021</last_update_submitted>
  <last_update_submitted_qc>November 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Alexander C. Egbe</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tetralogy of Fallot</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

